SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019647
Filing Date
2023-05-09
Accepted
2023-05-09 16:09:02
Documents
79
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kdny-20230331.htm   iXBRL 10-Q 2994478
2 EX-31.1 kdny-ex31_1.htm EX-31 20274
3 EX-31.2 kdny-ex31_2.htm EX-31 20265
4 EX-32.1 kdny-ex32_1.htm EX-32 10999
  Complete submission text file 0000950170-23-019647.txt   11174627

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kdny-20230331_lab.xml EX-101.LAB 511949
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kdny-20230331_cal.xml EX-101.CAL 59792
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kdny-20230331.xsd EX-101.SCH 68986
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kdny-20230331_def.xml EX-101.DEF 196551
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kdny-20230331_pre.xml EX-101.PRE 376387
73 EXTRACTED XBRL INSTANCE DOCUMENT kdny-20230331_htm.xml XML 2435177
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 23902026
SIC: 2834 Pharmaceutical Preparations